Cytokine profiling in 128 patients with transient abnormal myelopoiesis: a report from the JPLSG TAM-10 trial
Blood Adv. 2024 May 1:bloodadvances.2023011628. doi: 10.1182/bloodadvances.2023011628. Online ahead of print. ABSTRACT Transient abnormal myelopoiesis (TAM) occurs in 10% of neonates with Down syndrome (DS). …